Antiphospholipid antibodies bind to activated but not resting endothelial cells: Is an independent triggering event required to induce antiphospholipid antibody-mediated disease?

Thrombosis Research

Volumn 114, Issue 2, 2004, Pages 101-111

  Chen, Q ^a   Stone, P R ^a   Woon, S T ^b   Ching, L M ^b   Hung, S ^b   McCowan, L M E ^a   Chamley, L W ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

2 glycoprotein I; aCL; Activation; Anticardiolipin; anticardiolipin antibodies; antiphospholipid antibodies; Antiphospholipid antibodies; aPL; Endothelial; human umbilical vein endothelial cell(s); HUVEC(s); PBS; Phosphatidyl serine; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CELL ADHESION MOLECULE; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN;

ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS; UMBILICAL VEIN;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIGEN-ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; PLATELET ACTIVATION; PROTEIN BINDING; UMBILICAL VEINS;

EID: 4043167646     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.04.013     Document Type: Article

References (38)

1. Harris E.N., Hughes G.R., Gharavi A.E. Antiphospholipid antibodies: an elderly statesman Dons new garments. J. Rheumatol. 14(Suppl. 13):1987;208-213
2. Kushner M.J. Prospective study of anticardiolipin antibodies in stroke. Stroke. 21:1990;295-298
3. Pattison N.S., Chamley L.W., Liggins G.C., Butler W.S., McKay E.J. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br. J. Obstet. Gynaecol. 100:1993;909-913
4. 2 glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179:1994;457-462
5. 2 glycoprotein 1 in the absence of phospholipid. J. Immunol. 54:1995;954-960
6. Chamley L.W., Duncalf A.M., Konarkowska B., Mitchell M.D., Johnson P.M. Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies. Clin. Exp. Immunol. 15(3):1999;571-576
7. Conti F., Sorice M., Circella A., Alessandri C., Pittoni V., Caronti B., et al. Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression. Clin. Exp. Immunol. 132(3):2003;509-516
8. Daleke D.L., Lyles J.V. Identification and purification of aminophospholipid flippases. Biochim. Biophys. Acta. 1486(1):2000 (June 26);108-127
9. Bevers E.M., Comfurius P., Dekkers D.W., Harmsma M., Zwaal R.F. Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling. Lupus. 7(Suppl. 2):1998;S126-S131
10. Roubey R.A., Eisenberg R.A., Harper M.F., Winfield J.B. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J. Immunol. 154(2):1995 (Jan. 15);954-960
11. Williams F.M., Parmar K., Hughes G.R., Hunt B.J. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb. Haemost. 84(5):2000;742-746
12. Del Papa N., Guidali L., Spatola L., Bonara P., Borghi M.O., Tincani A., et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin. Exp. Rheumatol. 13(2):1995;179-185
13. Del Papa N., Guidali L., Sala A., Buccellati C., Khamashta M.A., Ichikawa K., et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum. 40(3):1997;551-561
14. Hanly J.G., Hong C., Issekutz A. Beta 2-glycoprotein I and anticardiolipin antibody binding to resting and activated cultured human endothelial cells. J. Rheumatol. 23(9):1996;543-549
15. Frijns C.J., Derksen R.H., De Groot P.G., Algra A., Fijnheer R. Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin. Exp. Immunol. 125(1):2001;149-154
16. Raschi E., Testoni C., Bosisio D., Borghi M.O., Koike T., Mantovani A., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 101(9):2003;3495-3500
17. Chamley L.W., Duncalf A.M., Mitchell M.D., Johnson P.M. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet. 352(9133):1998 (Sep. 26);1037-1038
18. Wilson W.A., Gharavi A.E., Piette J.C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus. 10(7):2001;457-460
19. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42(7):1999 (Jul.);1309-1311
20. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52(11):1973;2745-2756
21. Chamley L.W., Konarkowska B., Duncalf A.M., Mitchell M.D., Johnson P.M. Is interleukin-3 important in antiphospholipid antibody-mediated pregnancy failure? Fertil. Steril. 76(4):2001;700-706
22. Ching L.-M., Young H.A., Eberly K., Yu C.-R. Induction of STAT and NFκB activation by the antitumor agent 5, 6-dimethylxanthenone-4-acetic acid and flavoneacetic acid in a murine macrophage line. Biochem. Pharmacol. 58:1999;1173-1181
23. Sen R., Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 47(6):1986;921-928
24. Price B.E., Rauch J., Shia M.A., Walsh M.T., Lieberthal W., Gilligan H.M., et al. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J. Immunol. 157(5):1996;2201-2208
25. Ching L.M., Cao Z., Kieda C., Zwain S., Jameson M.B., Baguley B.C. Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanrthenone-4-acetic acid. Br. J. Cancer. 86:2002;1937-1942
26. Chamley L.W. Antiphospholipid antibodies: biological basis and prospects for treatment. J. Reprod. Immunol. 57(1-2):2002;185-202
27. Melrose J., Tsurushita N., Liu G., Berg E.L. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J. Immunol. 161(5):1998;2457-2464
28. Meroni P.L., Raschi E., Testoni C., Tincani A., Balestrieri G., Molteni R., et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum. 44(12):2001;2870- 2878
29. Levine J.S., Koh J.S., Subang R., Rauch J. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome. Exp. Mol. Pathol. 66(1):1999;82-98
30. Gharavi A.E., Pierangeli S.S., Stanfield M., Liu X.W., Espinola R.G., Harris E.N. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J. Immunol. 163(5):1999;2922-2927
31. Pierangeli S.S., Colden-Stanfield M., Liu X., Barker J.H., Anderson G.L., Harris E.N. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation. 99(15):1999;1997-2002
32. Pierangeli S.S., Liu X., Espinola R., Olee T., Zhu M., Harris N.E., et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb. Haemost. 84(3):2000;388-395
33. Out H.J., de Groot P.G., Hasselaar P., dan Vliet M., Derksen R.H. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann. Rheum. Dis. 48(12):1989;1023-1028
34. Combes V., Simon A.C., Grau G.E., Arnoux D., Camoin L., Sabatier F., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104(1):1999 (Jul.);93-102
35. Ma K., Simantov R., Zhang J.C., Silverstein R., Hajjar K.A., McCrae K.R. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J. Biol. Chem. 275(20):2000;15541-15548
36. Rand J.H., Wu X.X. Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome. Thromb. Haemost. 82(2):1999;649-655
37. Rand J.H., Wu X.X., Quinn A.S., Chen P.P., McCrae K.R., Bovill E.G., et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am. J. Pathol. 163(3):2003;1193-1200
38. Gharavi A.E., Cucurull E., Tang H., Silver R.M., Branch D.W. Effect of antiphospholipid antibodies on beta (2) glycoprotein I-phospholipid Interaction. Am. J. Reprod. Immunol. 39(5):1998;310-315